World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $860.48bn | 81.68 | 0.52% |
NOVO BNovo Nordisk A/S | DKK4.44tn | 50.5 | 0.93% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $351.76bn | 15.5 | 3.26% |
MRKMerck & Co | $313.56bn | 18.38 | 2.42% |
ABBVAbbvie | $302.88bn | 33.89 | 3.49% |
AZNAstraZeneca | £191.55bn | 43.62 | 1.86% |
ROGRoche Holding AG | CH₣199.63bn | 13.91 | 3.83% |
RORoche Holding AG | CH₣199.63bn | 15.3 | 3.49% |
NOVNNovartis AG | CH₣186.75bn | 18.67 | 3.69% |
AMGNAmgen | $167.61bn | 45.99 | 2.77% |
PFEPfizer | $158.55bn | 9.97 | 5.9% |
SANSanofi SA | €112.55bn | 17.02 | 4.18% |
CSLCSL | AU$141.35bn | 36.84 | 1.31% |
GILDGilead Sciences | $85.48bn | 11.48 | 4.4% |
CELG RTBristol-Myers Squibb Co | $84.19bn | 0.01 | 5634.15% |
BMYBristol-Myers Squibb Co | $84.19bn | 11.11 | 5.56% |
GSKGSK | £63.40bn | 12.11 | 3.86% |
ZTSZoetis | $79.10bn | 33.09 | 0.9% |
MCKMcKesson | $75.76bn | 26.02 | 0.4% |